Phase I randomized dose-ascending placebo-controlled trials of ferroquine - a candidate anti-malarial drug - in adults with asymptomatic <it>Plasmodium falciparum </it>infection

Phase I randomized dose-ascending placebo-controlled trials of ferroquine - a candidate anti-malarial drug - in adults with asymptomatic <it>Plasmodium falciparum </it>infection

<p>Abstract</p> <p>Background</p> <p>The development and spread of drug resistant <it>Plasmodium falciparum </it>strains is a major concern and novel anti-malarial drugs are, therefore, needed. Ferroquine is a ferrocenic derivative of chloroquine with proven...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Ospina Salazar Carmen L, Matsiegui Pierre-Blaise, Missinou Michel A, Dal-Bianco Matthias P, Supan Christian, Mombo-Ngoma Ghyslain, Issifou Saadou, Ter-Minassian Daniel, Ramharter Michael, Kombila Maryvonne, Kremsner Peter G, Lell Bertrand
פורמט: Article
שפה:English
יצא לאור: BMC 2011-03-01
סדרה:Malaria Journal
גישה מקוונת:http://www.malariajournal.com/content/10/1/53

אינטרנט

http://www.malariajournal.com/content/10/1/53

פריטים דומים